Instil Bio Inc. (TIL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $41.23M
Last updated: Nov 17, 2026 at 11:03 AM ET
Instil Bio Inc. (TIL) Earnings: Report Dates and Results
Instil Bio (TIL) is expected to report earnings on Mar 25, 2027. In the quarter ended Jun 30, 2026, Instil Bio reported EPS of -$0.63, below the -$0.35 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
TIL has an expected report date of Mar 25, 2027.
Earnings History
Of the 22 quarters below that had an estimate, TIL beat 7 and missed 15. The widest gap in the table came in the quarter ended Jun 30, 2026, when EPS landed 80.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.63 | -$0.35 | -$0.35 - -$0.35 | -80.00% | Miss | N/A | 1 | 1 up, 0 down | Aug 13, 2026 |
| Mar 31, 2026 | -$0.62 | -$0.59 | -$0.62 - -$0.56 | -5.08% | Miss | N/A | 2 | 1 up, 0 down | May 15, 2026 |
| Dec 31, 2025 | -$0.97 | -$3.78 | -$3.78 - -$3.78 | +74.34% | Beat | N/A | 1 | 1 up, 0 down | Mar 27, 2026 |
| Sep 30, 2025 | -$2.01 | -$2.35 | N/A | +14.47% | Beat | N/A | 1 | 1 up, 0 down | Nov 13, 2025 |
| Jun 30, 2025 | -$2.88 | -$2.44 | -$2.44 - -$2.44 | -18.03% | Miss | N/A | 1 | 1 up, 0 down | Aug 13, 2025 |
| Mar 31, 2025 | -$4.32 | -$2.59 | N/A | -66.80% | Miss | N/A | 1 | 1 up, 0 down | May 13, 2025 |
| Dec 31, 2024 | -$1.08 | -$3.65 | -$3.65 - -$3.65 | +70.41% | Beat | N/A | 1 | 0 up, 1 down | Mar 4, 2025 |
| Sep 30, 2024 | -$2.55 | -$3.08 | -$3.08 - -$1.08 | +17.21% | Beat | N/A | 4 | 0 up, 0 down | Nov 13, 2024 |
| Jun 30, 2024 | -$1.57 | -$3.04 | -$3.04 - -$2.92 | +48.36% | Beat | N/A | 2 | 0 up, 0 down | Aug 13, 2024 |
| Mar 31, 2024 | -$3.74 | -$2.23 | -$2.30 - -$2.16 | -67.71% | Miss | N/A | 2 | 0 up, 0 down | May 10, 2024 |
| Dec 31, 2023 | -$1.26 | -$3.40 | -$3.40 - -$2.29 | +62.94% | Beat | N/A | 2 | 0 up, 0 down | Mar 21, 2024 |
| Sep 30, 2023 | -$3.20 | -$3.00 | -$3.00 - -$1.20 | -6.67% | Miss | N/A | 4 | 0 up, 0 down | Nov 13, 2023 |
| Jun 30, 2023 | -$2.20 | -$2.00 | -$5.20 - -$2.00 | -10.00% | Miss | N/A | 3 | 0 up, 0 down | Aug 14, 2023 |
| Mar 31, 2023 | -$5.00 | -$3.20 | -$3.20 - -$3.00 | -56.25% | Miss | N/A | 2 | 0 up, 0 down | May 11, 2023 |
| Dec 31, 2022 | -$0.24 | -$0.41 | -$0.42 - -$0.40 | +41.46% | Beat | N/A | 3 | 0 up, 0 down | Mar 27, 2023 |
| Sep 30, 2022 | -$8.60 | -$8.20 | -$9.40 - -$8.00 | -4.88% | Miss | N/A | 5 | 0 up, 0 down | Nov 14, 2022 |
| Jun 30, 2022 | -$9.20 | -$8.27 | -$8.80 - -$7.60 | -11.25% | Miss | N/A | 5 | 0 up, 0 down | Aug 12, 2022 |
| Mar 31, 2022 | -$8.40 | -$6.50 | N/A | -29.23% | Miss | N/A | 3 | 0 up, 0 down | May 16, 2022 |
| Dec 31, 2021 | -$0.43 | -$0.36 | -$0.39 - -$0.32 | -19.44% | Miss | N/A | 4 | N/A | Mar 7, 2022 |
| Sep 30, 2021 | -$6.60 | -$6.13 | N/A | -7.67% | Miss | N/A | 5 | N/A | Nov 15, 2021 |
| Jun 30, 2021 | -$5.40 | -$4.00 | -$4.40 - -$4.00 | -35.00% | Miss | N/A | 4 | N/A | Aug 12, 2021 |
| Mar 31, 2021 | -$13.20 | -$11.90 | -$21.80 - -$2.00 | -10.92% | Miss | N/A | 4 | N/A | May 13, 2021 |
| Dec 31, 2020 | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 22, 2021 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$10.18, after -$8.94 the year before. It was -$0.15 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$10.18 | N/A |
| Dec 31, 2024 | -$8.94 | N/A |
| Dec 31, 2023 | -$11.66 | N/A |
| Dec 31, 2022 | -$26.44 | N/A |
| Dec 31, 2021 | -$25.63 | N/A |
| Dec 31, 2020 | -$0.15 | N/A |
Frequently Asked Questions About TIL
When is Instil Bio's next earnings date?
Instil Bio's next earnings report is expected for Mar 25, 2027.
Did TIL beat earnings estimates last quarter?
No. Instil Bio reported EPS of -$0.63 for the quarter ended Jun 30, 2026, below the -$0.35 estimate by 80.00%.
What EPS do analysts expect from TIL next quarter?
The consensus EPS estimate for Instil Bio for the quarter ending Dec 31, 2026 is -$0.04 from 2 analysts, with estimates from -$0.04 to -$0.04.
How often does TIL beat earnings estimates?
Instil Bio beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +0.81%.
TIL pages: Overview, Earnings, Forecast, Financials, Competitors